Product Specifications: Composition: Water for Injection, USP with 0.9% (9 mg/mL) Benzyl Alcohol, NF (bacteriostatic preservative) Volume: 30mL per sterile vial Container Type: Type I borosilicate glass vial with sterile rubber closure and aluminum overseal pH: 4.5 7.0 (per USP monograph) Osmolality: Hypotonic (approximately 0 mOsm/kg) Sterility Assurance Level: 10 (terminal steam sterilization) Bacterial Endotoxin: Bacterial Endotoxins Test Particulate Matter: Complies with USP Particulate Matter specifications FOR RESEARCH USE ONLY
Differential Diagnosis Clinical Indicators for Coders/CDI Documentation of malnutrition must meet ICD-10-CM Official Guidelines Section I.C.4 (Endocrine, Nutritional, and Metabolic Diseases)
1 week (4 vials 2.0 mL = 8 mL) 1 10 mL bottle 2 weeks (7 vials 2.0 mL = 14 mL) 2 10 mL bottles 4 weeks (14 vials 2.0 mL = 28 mL) 3 10 mL bottles Alcohol Swabs: One for the vial stopper + one for the injection site each administration
applications leverage the fragments small size, membrane permeability, and Analytical Validation and Quality Features TB500 Fragment (1723) is supplied by research vendors as a lyophilized powder at defined peptide content per vial (e.g., 10 mg)
This content should not be interpreted as medical advice, a recommendation for treatment, or evidence of established clinical effectiveness